Publications

Research Gate:

https://www.researchgate.net/profile/Sandeep_Mallipattu/contributions

Google Scholar:

http://scholar.google.com/citations?user=-v0QQj8AAAAJ&hl=en

Pubmed: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/45234744/?sort=date&direction=descending

Key Publications:

1.Mallipattu SK* et al. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. The Journal of biological chemistry (2012) 287(23):19122-35. doi: 10.1074/jbc.M112.345983. PubMed PMID: 22493483.
 
2.Zhong Y, Wu Y, Liu R, Deng Y, Mallipattu SK*, Klotman PE, et al. Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure. Kidney international (2012) 81(9):856-64. doi: 10.1038/ki.2011.467. PubMed PMID: 22258322.
 
3.Mallipattu SK*, He JC, Uribarri J. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Seminars in dialysis (2012) 25(5):529-38. doi: 10.1111/j.1525-139X.2012.01081.x. PubMed PMID: 22548330.
 
4.Mallipattu SK*, Wyatt CM, He JC. The New Epidemiology of HIV-Related Kidney Disease. Journal of AIDS & clinical research (2012) Suppl 4:001. doi: 10.4172/2155-6113.S4-001. PubMed PMID: 25309811.
 
5.Zhong Y, Chen EY, Liu R, Chuang PY, Mallipattu SK*, Tan CM, He JC. Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase. Journal of the American Society of Nephrology : JASN (2013) 24(5):801-11. doi: 10.1681/ASN.2012060590. PubMed PMID: 23559582.
 
6.Mallipattu SK*, Liu R, Zhong Y, Chen EY, D'Agati V, Kaufman L, et al. Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney international (2013) 83(4):626-34. doi: 10.1038/ki.2012.445. PubMed PMID: 23325078.
 
7.Mallipattu SK*, He JC. A new mechanism for albuminuria-induced podocyte injury. Journal of the American Society of Nephrology : JASN (2013) 24(11):1709-11. doi: 10.1681/ASN.2013070714. PubMed PMID: 23990672.
 
8.Gu L, Dai Y, Xu J, Mallipattu SK*, Kaufman L, Klotman PE, et al. Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS (London, England) (2013) 27(7):1091-8. doi: 10.1097/QAD.0b013e32835f1ea1. PubMed PMID: 23343908.
 
9.Mallipattu SK* et al. Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus. American journal of physiology Renal physiology (2014) 306(9):F1008-17. doi: 10.1152/ajprenal.00597.2013. PubMed PMID: 24598803.
 
10.Mallipattu SK*, Uribarri J. Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease? Current opinion in nephrology and hypertension (2014) 23(6):547-54. doi: 10.1097/MNH.0000000000000062. PubMed PMID: 25160075.
 
11.Mallipattu SK*, Salem F, Wyatt CM. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney international (2014) 86(2):259-65. doi: 10.1038/ki.2014.44. PubMed PMID: 24573317.
 
12.Chuang PY, Xu J, Dai Y, Jia F, Mallipattu SK*, Yacoub R, He JC. In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. The American journal of pathology (2014) 184(7):1940-56. Epub 2014/06/24. doi: 10.1016/j.ajpath.
 
13.Zhong F, Chen H, Wei C, Zhang W, Li Z, Jain MK, Mallipattu SK*, He JC. Reduced Kruppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy. Kidney international (2015) 87(2):382-95. doi: 10.1038/ki.2014.286. PubMed PMID: 25185079; PubMed Central PMCID: PMC4312548.
 
14.Mallipattu SK* et al. Kruppel-like factor 6 regulates mitochondrial function in the kidney. The Journal of clinical investigation (2015). doi: 10.1172/JCI77084. PubMed PMID: 25689250.
 
15.Mallipattu SK*, He JC. The Beneficial Role of Retinoids in Glomerular Disease. Frontiers in Medicine (2015). 10.3389/fmed.2015.00016.
 
16.Mallipattu SK*, He JC. KLF6: a mitochondrial regulator in the kidney. Oncotarget (2015).
 
17.Mallipattu SK* et al. Krüppel-like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers. Journal of the American Society of Nephrology (2016). doi: 10.1681/ASN.2015060672. PubMed PMID: 27288011. 
 
18.Mallipattu SK*, He JC. The podocyte as a direct target for treatment of glomerular disease? American journal of physiology Renal physiology (2016);311(1):F46-51. doi: 10.1152/ajprenal.00184.2016. PubMed PMID: 27097894.
 
19.Zhong F, Mallipattu SK*, Estrada C, Menon M, Salem F, Jain MK, et al. Reduced Krüppel-like Factor 2 Aggravates Glomerular Endothelial Cell Injury and Kidney Disease in Mice with Unilateral Nephrectomy. The American journal of pathology (2016). 186(8):2021-31. doi: 10.1016/j.ajpath.2016.03.018. PubMed PMID: 27317905.
 
20.Mallipattu SK* et al. The critical role of Krüppel-like factors in kidney disease. American journal of physiology Renal physiology (2016). ajprenal 00550 2016. doi: 10.1152/ajprenal.00550.2016. PubMed PMID: 27852611.
21.Bialkowska AB, Yang VW, Mallipattu SK*. Kruppel-like factors in mammalian stem cells and development. Development (2017). 144(5):737-54. doi: 10.1242/dev.145441. PubMed PMID: 28246209. 
 
22.Mallipattu SK* et al. The loss of Krüppel-like factor 15 in Foxd1+ stromal cells exacerbates kidney fibrosis. Kidney International (2017). pii: S0085-2538(17)30246-6. doi: 10.1016/j.kint.2017.03.037. PubMed PMID: 28651950.